# Methotrexate and Cyclosporine in Treatment of Early Rheumatoid Arthritis

> **NCT00209859** · PHASE4 · COMPLETED · sponsor: **Hvidovre University Hospital** · enrollment: 160 (—)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Methotrexate
- **DRUG:** Intraarticular betamethasone
- **DRUG:** Cyclosporine/placebo-cyclosporine

## Key facts

- **NCT ID:** NCT00209859
- **Lead sponsor:** Hvidovre University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-10
- **Primary completion:** —
- **Final completion:** 2007-11
- **Target enrollment:** 160 (—)
- **Last updated:** 2005-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00209859

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00209859, "Methotrexate and Cyclosporine in Treatment of Early Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00209859. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*